CORT

Corcept Therapeutics (CORT)

About Corcept Therapeutics (CORT)

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Details

Daily high

$82.00

Daily low

$77.38

Price at open

$80.70

52 Week High

$91.00

52 Week Low

$28.66

Market cap

8.6B

Dividend yield

0.00%

Volume

882,898

Avg. volume

1.0M

P/E ratio

228.31

Corcept Therapeutics News